Biotech Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia July 5, 2024
Biotech Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada July 5, 2024
Biotech Specialty Enzymes Market worth $9.2 billion by 2029 – Exclusive Report by MarketsandMarkets™ July 3, 2024
Biotech Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences July 3, 2024